MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial

BACKGROUND AND PURPOSE—: This study aimed to assess the efficacy of modafinil, a wakefulness-promoting agent in alleviating post-stroke fatigue ≥3 months after stroke. We hypothesized that 200 mg of modafinil daily for 6 weeks would result in reduced symptoms of fatigue compared with placebo. METHOD...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Stroke
Päätekijät: Bivard, Andrew, Lillicrap, Thomas, Krishnamurthy, Venkatesh, Holliday, Elizabeth, Attia, John, Pagram, Heather, Nilsson, Michael, Parsons, Mark, Levi, Christopher R.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Lippincott Williams & Wilkins 2017
Aiheet:
Original Contributions
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404401/
https://ncbi.nlm.nih.gov/pubmed/28404841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.016293
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia